GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medartis Holding MED.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

108.40

-1.09%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

CHF 269.3m

FY2016FY2025

Net income

CHF 8.3m

FY2016FY2025

Free cash flow

CHF 9.3m

FY2016FY2025

Shareholders' equity

CHF 275.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCHF 269.3mCHF 224.8mCHF 212.0mCHF 182.8mCHF 159.9mCHF 127.6mCHF 130.1mCHF 121.3mCHF 105.0mCHF 92.5m
Gross profitCHF 204.3mCHF 178.7mCHF 167.6mCHF 135.4mCHF 121.6mCHF 93.9mCHF 101.3mCHF 101.0mCHF 87.6mCHF 76.0m
Research and developmentCHF 31.4mCHF 43.1mCHF 25.9mCHF 23.5mCHF 20.0mCHF 16.2mCHF 13.7mCHF 13.2mCHF 11.4mCHF 9.5m
Operating incomeCHF 1.9mCHF 7.9mCHF 9.1m−CHF 5.1mCHF 12.4mCHF 3.1mCHF 7.4mCHF 6.1mCHF 9.6mCHF 7.2m
Net incomeCHF 8.3mCHF 3.5mCHF 619,000−CHF 5.8mCHF 6.8m−CHF 943,565CHF 2.1mCHF 4.2mCHF 866,521CHF 3.3m
Diluted earnings per share0.670.280.05-0.490.58-0.080.180.370.070.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCHF 559.9mCHF 460.0mCHF 349.5mCHF 327.9mCHF 298.2mCHF 282.8mCHF 288.5mCHF 255.8mCHF 130.5mCHF 115.2m
Cash and short-term investmentsCHF 33.0mCHF 138.7mCHF 25.2mCHF 20.6mCHF 82.6mCHF 82.7mCHF 99.6mCHF 116.3mCHF 2.0mCHF 1.8m
Total liabilitiesCHF 284.1mCHF 190.3mCHF 94.6mCHF 90.1mCHF 74.2mCHF 69.8mCHF 72.9mCHF 37.6mCHF 113.5mCHF 98.1m
DebtCHF 139.0mCHF 129.4mCHF 50.6mCHF 52.0mCHF 24.1mCHF 27.2mCHF 26.4mCHF 3.4mCHF 74.6mCHF 64.7m
Shareholders' equityCHF 275.9mCHF 269.6mCHF 255.0mCHF 237.8mCHF 224.0mCHF 213.0mCHF 215.6mCHF 218.2mCHF 17.0mCHF 17.1m
Shares outstanding12m12m12m12m12m12m12m11m13m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCHF 34.8mCHF 32.1mCHF 20.0m−CHF 3.9mCHF 21.0mCHF 12.6mCHF 8.1mCHF 6.4mCHF 11.0mCHF 11.9m
Capital spending−CHF 25.5m−CHF 7.2m−CHF 14.9m−CHF 18.8m−CHF 10.4m−CHF 13.1m−CHF 19.4m−CHF 14.5m−CHF 8.8m−CHF 8.5m
Free cash flowCHF 9.3mCHF 24.9mCHF 5.0m−CHF 22.7mCHF 10.6m−CHF 455,286−CHF 11.3m−CHF 8.0mCHF 2.2mCHF 3.4m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCHF 160.8mCHF 146.2mCHF 123.0mCHF 113.3mCHF 111.5mCHF 108.8mCHF 103.3mCHF 94.4m
Gross profitCHF 131.4mCHF 106.5mCHF 97.8mCHF 89.1mCHF 89.6mCHF 87.8mCHF 79.7mCHF 75.6m
Operating incomeCHF 13.1m−CHF 8.2mCHF 9.3m−CHF 658,000−CHF 4.3mCHF 8.6mCHF 2.8m−CHF 3.2m
Net incomeCHF 5.1mCHF 9.8m−CHF 1.4mCHF 963,000CHF 2.6mCHF 1.5m−CHF 848,041−CHF 5.8m
Diluted earnings per share0.410.79-0.120.080.210.12-0.07-0.49
Cash from operationsCHF 5.0mCHF 24.0mCHF 6.0mCHF 18.0mCHF 9.0mCHF 22.0m−CHF 2.0m—
Capital spending−CHF 15.0m−CHF 12.0m−CHF 5.0m−CHF 2.0m−CHF 5.0m−CHF 9.0m−CHF 9.0m−CHF 10.0m
Free cash flow−CHF 10.0mCHF 12.0mCHF 1.0mCHF 16.0mCHF 4.0mCHF 13.0m−CHF 11.0m—
Total assetsCHF 610.0mCHF 559.9mCHF 465.7mCHF 460.0mCHF 464.5mCHF 349.5mCHF 354.8mCHF 327.9m
Cash and short-term investmentsCHF 25.8mCHF 33.0mCHF 120.5mCHF 138.7mCHF 127.1mCHF 25.2mCHF 15.0mCHF 20.6m
DebtCHF 10.6mCHF 139.0mCHF 8.1mCHF 102.9mCHF 7.2mCHF 6.8mCHF 7.0mCHF 6.1m
Shareholders' equityCHF 281.9mCHF 275.9mCHF 261.2mCHF 269.6mCHF 272.6mCHF 255.0mCHF 265.0mCHF 237.8m

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin75.9%79.5%79.0%74.1%76.0%73.6%
Operating margin7.5%3.5%5.4%-1.4%6.1%-1.5%
Net margin3.1%1.6%0.3%-3.2%4.3%-0.7%
Return on equity3.0%1.3%0.2%-2.4%3.1%-0.4%
Return on assets1.5%0.8%0.2%-1.8%2.3%-0.3%
Free cash flow yield4.4%2.9%2.6%1.1%2.4%2.0%
Revenue growth19.8%6.0%16.0%14.4%25.3%-1.9%
Earnings growth136.6%470.0%-110.7%-184.6%-824.7%-144.0%
Current ratio2.21x5.21x3.08x3.49x5.06x6.28x
Debt to equity0.50x0.38x0.03x0.03x0.02x0.02x
Equity ratio49.3%58.6%72.9%72.5%75.1%75.3%
Interest coverage2.71x1.16x6.62x-0.53x6.61x-1.40x
R&D as a share of sales11.7%19.2%12.2%12.9%12.5%12.7%
Buybacks as a share of market value-0.4%-0.3%-4.4%-0.2%-0.3%-0.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.8%16.1%12.6%
Operating income—-9.2%-16.8%
Net income——1.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin77.5%77.2%76.6%78.2%
Operating margin2.0%1.6%2.5%4.2%
Net margin2.4%0.8%1.1%1.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings133.2198.9—-167.8225.0-580.4239.0150.4
Price to sales4.13.14.95.39.64.33.95.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.